Delivery Order SPE2DB22D3019-SPE2DB25FK4GC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,080.19 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. This contract represents a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and was competitively awarded without set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,509.04 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This non-competitive delivery order carries a firm fixed price arrangement and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $6,956.52 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 50 mg, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,663.10. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded competitively without set-aside provisions, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. Valued at $1,016.18 with firm fixed pricing, this non-set-aside delivery order is scheduled for completion by August 20, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. The contract carries a ceiling value of $19,708.52 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025. This award was made on a competitive basis without set-aside designation, with performance to be executed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,733.57 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. The contract is a firm fixed price delivery order with an ultimate completion date of August 27, 2025, and was awarded on August 26, 2025. No set-aside designation was applied to this award, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,414.81 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,674.46. This award is issued as a firm fixed price delivery order with an ultimate completion date of June 25, 2025, and represents a non-competitive set-aside award. The contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,735.94 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-competed award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is issued as a child delivery order...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4GCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Losartan Potassium 50 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order, valued at $4,386.56, was executed on September 17, 2025, with an ultimate completion date of September 18, 2025. The contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle valued through December 2026 that supports military healthcare programs globally. AmerisourceBergen Drug Corp, as a critical federal medical procurement vendor, maintains an extensive portfolio of pharmaceutical and medical supply deliveries primarily through the Defense Logistics Agency and its Medical Supply Chain, servicing the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its expansive pharmaceutical inventory spanning multiple therapeutic domains, positions it as a key provider within DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/17/25 |